Introduction
Beta-thalassemia major (TM) patients have a severe anemia requiring lifelong transfusion to allow normal development and prolong survival. Left ventricular volumes and ejection fraction in these patients differ from the normal population because of chronically increased cardiac output, and this can affect the interpretation of scan results. However, normal ranges for RV parameters and function are unknown.
Purpose
To define the normal ranges for RV volumes and ejection fraction (EF) in non-iron overloaded transfusion-dependent TM patients.
Methods
Our study population consisted of 80 transfusiondependent TM patients (40 males and 40 females) with no evidence of cardiac iron loading (cardiac T2* > 20 ms). Only those over 18 with no evidence of significant cardiopulmonary pathology were included. To control for different iron chelators and possible treatment effect, patients included in the analysis were presenting for their first scan and were only taking a single chelation agent (deferoxamine). Forty age-and sex-matched patients acted as controls. RV volumes and EF were measured from short-axis steady-state free precession cine images using CMRtools (Cardiovascular Imaging Solutions, London). Groups were compared using a two-tailed, two sample ttest.
Results
Both groups were well matched with respect to age and gender but the TM patients (as would be expected) had significantly lower height, weight and body surface area than non-anemic controls (P < 0.05). Body mass index was equivalent in females but slightly lower in male TM patients compared to controls. TM patients had a significantly higher resting heart rate (P < 0.05). Mean RV enddiastolic volume index was higher in TM patients than controls (but this did not reach significance for females). Although the absolute value for mean RV end-systolic volume index was lower in TM patients, there was no significant difference for either gender. In both males and females, the TM patients had a higher RV stroke volume, RVEF, cardiac output and cardiac output index (P < 0.05). See Tables 1, 2 
Conclusion
Our findings have confirmed that not only LV but also RV 'normal ranges' differ between patients with TM and normal, non-anemic controls. This partly explains why ventricular impairment appears to occur late in iron overload cardiomyopathy. The lower limit of RVEF in TM patients is significantly higher than in normal controls and therefore, if the wrong reference range is used, a cardiomyopathy may exist even though the RVEF appears to be 'normal'. It is important to take this into account when assessing RV function in TM patients. 1.65 ± 0.1 1.80 ± 0.09 < 0.001 1.54 ± 8.9 1.67 ± 9.2 < 0.001 Weight (kg) 59.1 ± 8.9 75.8 ± 9.9 < 0.001 53.3 ± 10.1 61.4 ± 11.3 0.006 BMI (kg/m 2 ) 21.9 ± 3.1 23.6 ± 3.1 0.048 22.5 ± 4.5 22.0 ± 2.8 0.68 BSA (m 2 )
1.64 ± 0.16 1.94 ± 0.15 < 0.001 1.50 ± 0.15 1.68 ± 0.18 < 0.001 Heart rate (min -1 ) 72.7 ± 10.4 64.0 ± 9.5 < 0.05 78.8 ± 10.1 64.8 ± 13.6 < 0.001 Figure 1 
